Get tips and insights from health-care professionals and people with diabetes, share your thoughts, and ask questions on our blog.

Diabetes Flashpoints

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics

Print |

Text Size:

August 28, 2009

Product Discontinuations

Diane Fennell

Recent weeks have brought word about several diabetes products that are scheduled to be discontinued within the next year.

Eli Lilly and Company has decided to stop producing Humulin 50/50, a premixed insulin consisting of 50% NPH suspension and 50% Regular insulin. Based on its current supply, Eli Lilly anticipates that the insulin, which is used by roughly 3,000 people nationwide, will be available in pharmacies through the end of April 2010. (This does not affect the availability of Humalog 50/50 insulin.)

Additionally, Novo Nordisk will be discontinuing Novolin InnoLet disposable insulin pens and Novolin PenFill 3-milliliter insulin cartridges. The final date of sale for the Novolin R InnoLet, Novolin N InnoLet, Novolin 70/30 InnoLet, Novolin R PenFill 3-milliliter cartridges, Novolin N 3-milliliter cartridges, and NovoLin 70/30 PenFill 3-milliliter cartridges is December 31, 2009.

For more information about the discontinuation of Humulin 50/50 insulin, see the information sheet issued by Eli Lilly. And to learn more about the discontinuation of Novolin InnoLet pens and Novolin PenFill 3-milliliter insulin cartridges, read the information sheet supplied by Novo Nordisk.

POST A COMMENT

There are no comments at this time.

Name (required)

Email Address (will not be published) (required)

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. Be respectful of other posters. Only post information that is correct and true to your knowledge. When referencing information that is not based on personal experience, please provide links to your sources. All commenters are considered to be nonmedical professionals unless explicitly stated otherwise. Promotion of your own or someone else's business or competing site is not allowed: Sharing links to sites that are relevant to the topic at hand is permitted, but advertising is not. Once submitted, comments cannot be modified or deleted by their authors. Comments that don't follow the guidelines above may be deleted without warning. Such actions are at the sole discretion of DiabetesSelfManagement.com. Comments are moderated Monday through Friday by the editors of DiabetesSelfManagement.com. The moderators are employees of R.A. Rapaport Publishing, Inc., and do not report any conflicts of interest. A privacy policy setting forth our policies regarding the collection, use, and disclosure of certain information relating to you and your use of this Web site can be found here. For more information, please read our Terms and Conditions.

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.